- Drugs that affect body systems
- omega-3 fatty acids: mechanism for cardiovascular benefits in hypertension
- omega-3 fatty acid metabolites and their effect on abdominal aortic aneurysm
- anti-inflammatory and vascular effects of Australian stingless bee propolis
Dr Fraser Russell obtained his PhD in the laboratory of Prof. Roger Summers, Dept. of Pharmacology, University of Melbourne (1994), where he investigated regulation of β-adrenoceptors in the heart.
He completed successful post-doctoral studies in the Clinical Pharmacology Unit, University of Cambridge, UK (1994-1998) working with Dr Anthony Davenport, and then in the Dept. of Anatomy and Structural Biology, University of Otago, NZ working with A/Prof. Ian McLennan (1998-2000).
He returned to Australia in 2000 to take a Research Fellow position in the Dept. of Medicine, University of Queensland, studying the cardiostimulatory effects of urotensin-II in human heart with A/Prof. Peter Molenaar.
Dr Russell is currently a Senior Lecturer in Biochemical Pharmacology at the University of the Sunshine Coast (2005-present).
His research group is investigating the anti-inflammatory and pro-resolving properties of omega-3 fatty acids and their metabolites, and their ability to attenuate the progression of abdominal aortic aneurysm, and the wound-healing potential of Australian stingless bee propolis.
Dr Russell is an active member of the Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT, 1989-present), and member of the Editorial Board of ISRN Cardiology (2011-present), and Academic Editor of Cardiology and Angiology: An International Journal (2013-present).